Showing results (311-320 of 534) with videos related to
Sort By:
Pageof 54
Nature Medicine|September 11, 2007
Protein carbamylation links inflammation, smoking, uremia and atherogenesisZeneng Wang, Stephen J Nicholls, E Rene Rodriguez, et al.Journal of the American College of Cardiology|May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) studyMatthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.Journal of Medical Internet Research|September 16, 2015
How Consumers and Physicians View New Medical Technology: Comparative SurveyDebra L Boeldt, Nathan E Wineinger, Jill Waalen, et al.Circulation. Cardiovascular Genetics|May 29, 2014
A novel molecular diagnostic marker for familial and early-onset coronary artery disease and myocardial infarction in the LRP8 geneGong-Qing Shen, Domenico Girelli, Lin Li, et al.Circulation|July 9, 2003
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudyStefan K James, Bertil Lindahl, Agneta Siegbahn, et al.Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.BMC Genetics|February 21, 2004
Multivariate sib-pair linkage analysis of longitudinal phenotypes by three step-wise analysis approachesZheng Guo, Xia Li, Shaoqi Rao, et al.BMJ (Clinical Research Ed.)|March 28, 2020
Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studiesMyura Nagendran, Yang Chen, Christopher A Lovejoy, et al.JAMA|April 14, 2005
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trialsGiuseppe De Luca, Harry Suryapranata, Gregg W Stone, et al.The Journal of Pharmacology and Experimental Therapeutics|December 22, 2005
Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury modelKai Wang, Zhongmin Zhou, Ming Zhang, et al.Pageof 54